Professor Crabb congratulating Professor Lewin on her wonderful legacy at Burnet.
In a fitting tribute to a talented and inspirational researcher, many farewell events and speeches have been held at Burnet over the past few weeks to say goodbye to Professor Sharon Lewin and her team.
After 11 years with Burnet Institute, Professor Sharon Lewin will begin a new chapter in her career as the inaugural Director of the Doherty Institute, based at the University of Melbourne.
The Board and staff at Burnet Institute extend our congratulations on her breakthrough work here and wish her every success in her next endeavour.
Professor Lewin, a world-leading HIV researcher, was also Co-Head of Burnet’s Centre for Biomedical Research, and the Local Co-Chair of the prestigious AIDS 2014 Conference in Melbourne.
She made a number of scientific breakthroughs during her time at Burnet including the discovery that cancer drug, vorinostat lures ‘sleeping’ virus out of HIV-infected cells, bringing researchers a step closer to finding a cure.
Professor Lewin said she is looking forward to the new challenge of leading the Doherty Institute but leaves Burnet with mixed feelings.
“Burnet is full of passionate and hard-working people and I will miss many of my friends and collaborators here,” she said.
“I would like to thank all my Burnet colleagues, especially Professor Crabb, for their support, encouragement and inspiration during my time here.”
Burnet Institute Director and CEO, Professor Brendan Crabb said Professor Lewin leaves Burnet with a lasting legacy.
“Sharon has made a significant impact on all who have collaborated with her during her time at Burnet, especially through her clear strategic thinking, visionary outlook and inspirational mentoring,” Professor Crabb said.
“We are proud to have people of the calibre of Sharon working with us who are sought out for these prestigious roles.”
Professor Lewin said she is looking forward to developing opportunities for Burnet and Doherty staff to work closely together in the future.
The Doherty Institute will focus on research into infectious diseases, immunology and improving public health and safety.